The Craneware Group References Capped?

Access even more references from these marketplace competitors

  • 4.8 / 5.0 (1440)
    18+ References
  • 4.8 / 5.0 (901)
    11+ References
  • 4.8 / 5.0 (2022)
    14+ References

The Craneware Group Testimonials

  • “In 2021, Center for Drug Evaluation and Research (CDER) approved 50 new drugs. CDER identified 27 of the 50 novel drugs approved in 2021 (54%) as first-in-class.”

  • “Many hospitals wonder if the revenue is really there to be recovered. Our experience at St. Joseph proves that it is.”

  • currently locked
  • AccuReg
    Reference Rating
    4.8 / 5.0
    Customer References 18 total
    About

    AccuReg has one simple, clear focus: Optimizing the front-end of the revenue cycle. This is the best place to help the RCM industry perform better at a lower cost. In …

  • HealthPay24
    Reference Rating
    4.8 / 5.0
    Customer References 11 total
    About

    HealthPay24 is pioneering consumer-driven solutions for the ever-increasing patient pay responsibility. Both a provider and patient-facing solution, the platform infrastructure ensures the unique, ongoing ability to adopt emerging & AI …

  • RevSpring
    Reference Rating
    4.8 / 5.0
    Customer References 14 total
    About

    RevSpring is a leader in patient and consumer financial engagement delivering end-to-end technology-enabled solutions that accelerate cash flow, improve consumer satisfaction and strengthen client relationships. As a leading provider of …

  • currently locked
  • currently locked
  • currently locked
  • currently locked
  • currently locked
  • currently locked
  • currently locked
  • currently locked
  • currently locked
  • currently locked
  • currently locked
  • currently locked